Angiotensin-converting Enzyme Degrades Alzheimer Amyloid β-Peptide (Aβ); Retards Aβ Aggregation, Deposition, Fibril Formation; and Inhibits Cytotoxicity

Angiotensin-converting Enzyme Degrades Alzheimer Amyloid β-Peptide (Aβ); Retards Aβ Aggregation, Deposition, Fibril Formation; and Inhibits Cytotoxicity

We have demonstrated that the angiotensin-converting enzyme (ACE) genotype is associated with Alzheimer's disease (AD) in the Japanese population (1Hu J. Miyatake F. Aizu Y. Nakagawa H. Nakamura S. Tamaoka A. Takahashi R. Urakami K. Shoji M. Neurosci. Lett. 1999; 277: 65-67Crossref PubMed Scopu...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Jianguo Hu, Akira Igarashi, Makiko Kamata, Hachiro Nakagawa
Format:	Artigo
Sprache:	Englisch
Veröffentlicht:	2001
Online-Zugang:	https://doi.org/10.1074/jbc.m104068200 http://www.jbc.org/article/S0021925819402937/pdf
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge

The N‐terminal active centre of human angiotensin‐converting enzyme degrades Alzheimer amyloid β‐peptide
von: Ryutaro Oba, et al.
Veröffentlicht: (2005)

Angiotensin-Converting Enzyme Converts Amyloid β-Protein 1–42 (Aβ(1–42)) to Aβ(1–40), and Its Inhibition Enhances Brain Aβ Deposition
von: Zou, Kun, et al.
Veröffentlicht: (2007)

Charge Dependent Retardation of Amyloid β Aggregation by Hydrophilic Proteins
von: Assarsson, Anna, et al.
Veröffentlicht: (2014)

Charge Dependent Retardation of Amyloid β Aggregation by Hydrophilic Proteins
von: Anna Assarsson, et al.
Veröffentlicht: (2014)

New Insights on How Metals Disrupt Amyloid β-Aggregation and Their Effects on Amyloid-β Cytotoxicity
von: Yuji Yoshiike, et al.
Veröffentlicht: (2001)

Angiotensin-Converting Enzyme Converts Amyloid β-Protein 1–42 (Aβ<sub>1–42</sub>) to Aβ<sub>1–40</sub>, and Its Inhibition Enhances Brain Aβ Deposition
von: Kun Zou, et al.
Veröffentlicht: (2007)

Preventing β-amyloid fibrillization and deposition: β-sheet breakers and pathological chaperone inhibitors
von: Wisniewski, Thomas, et al.
Veröffentlicht: (2008)

Zinc as chaperone-mimicking agent for retardation of amyloid β peptide fibril formation
von: Abelein, Axel, et al.
Veröffentlicht: (2015)

Zinc as chaperone-mimicking agent for retardation of amyloid β peptide fibril formation
von: Axel Abelein, et al.
Veröffentlicht: (2015)

Microglia convert aggregated amyloid-β into neurotoxic forms through the shedding of microvesicles
von: Joshi, P, et al.
Veröffentlicht: (2014)

Microglia convert aggregated amyloid-β into neurotoxic forms through the shedding of microvesicles
von: P. Joshi, et al.
Veröffentlicht: (2013)

Aβ42-to-Aβ40- and Angiotensin-converting Activities in Different Domains of Angiotensin-converting Enzyme
von: Zou, Kun, et al.
Veröffentlicht: (2009)

Aβ42-to-Aβ40- and Angiotensin-converting Activities in Different Domains of Angiotensin-converting Enzyme
von: Kun Zou, et al.
Veröffentlicht: (2009)

TMPyP Inhibits Amyloid-β Aggregation and Alleviates Amyloid-Induced Cytotoxicity
von: Fan, Yujuan, et al.
Veröffentlicht: (2017)

Regulation of Steady-state β-Amyloid Levels in the Brain by Neprilysin and Endothelin-converting Enzyme but Not Angiotensin-converting Enzyme
von: Elizabeth A. Eckman, et al.
Veröffentlicht: (2006)

The Serpin-Enzyme Complex Receptor Recognizes Soluble, Nontoxic Amyloid-β Peptide but Not Aggregated, Cytotoxic Amyloid-β Peptide
von: Kimberly Boland, et al.
Veröffentlicht: (1996)

TDP-43 expression influences amyloid β plaque deposition and tau aggregation
von: Davis, Stephani A., et al.
Veröffentlicht: (2017)

TDP-43 expression influences amyloidβ plaque deposition and tau aggregation
von: Stephani A. Davis, et al.
Veröffentlicht: (2017)

Reduced Lipid Bilayer Thickness Regulates the Aggregation and Cytotoxicity of Amyloid-β
von: Korshavn, Kyle J., et al.
Veröffentlicht: (2017)

Reduced Lipid Bilayer Thickness Regulates the Aggregation and Cytotoxicity of Amyloid-β
von: Kyle J. Korshavn, et al.
Veröffentlicht: (2017)

The Binding of Apolipoprotein E to Oligomers and Fibrils of Amyloid-β Alters the Kinetics of Amyloid Aggregation
von: Garai, Kanchan, et al.
Veröffentlicht: (2014)

The Binding of Apolipoprotein E to Oligomers and Fibrils of Amyloid-β Alters the Kinetics of Amyloid Aggregation
von: Kanchan Garai, et al.
Veröffentlicht: (2014)

Conversion of Aβ43 to Aβ40 by the successive action of angiotensin‐converting enzyme 2 and angiotensin‐converting enzyme
von: Shuyu Liu, et al.
Veröffentlicht: (2014)

Brazilin inhibits amyloid β-protein fibrillogenesis, remodels amyloid fibrils and reduces amyloid cytotoxicity
von: Du, Wen-Jie, et al.
Veröffentlicht: (2015)

Brazilin inhibits amyloid β-protein fibrillogenesis, remodels amyloid fibrils and reduces amyloid cytotoxicity
von: Wenjie Du, et al.
Veröffentlicht: (2015)

Cytotoxicity of Amyloid β1–42 Fibrils to Brain Immune Cells
von: Mikhail Matveyenka, et al.
Veröffentlicht: (2025)

Tanshinones Inhibit Amyloid Aggregation by Amyloid-β Peptide, Disaggregate Amyloid Fibrils, and Protect Cultured Cells
von: Wang, Qiuming, et al.
Veröffentlicht: (2013)

Tanshinones Inhibit Amyloid Aggregation by Amyloid-β Peptide, Disaggregate Amyloid Fibrils, and Protect Cultured Cells
von: Qiuming Wang, et al.
Veröffentlicht: (2013)

Amyloid β-Protein Is Degraded by Cellular Angiotensin-converting Enzyme (ACE) and Elevated by an ACE Inhibitor
von: Hemming, Matthew L., et al.
Veröffentlicht: (2005)

Kinetic and structural characterization of amyloid‐β peptide hydrolysis by human angiotensin‐1‐converting enzyme
von: Larmuth, Kate M., et al.
Veröffentlicht: (2016)

Amyloid β-Protein Is Degraded by Cellular Angiotensin-converting Enzyme (ACE) and Elevated by an ACE Inhibitor
von: Matthew L. Hemming, et al.
Veröffentlicht: (2005)

A New Motif in the N‐Terminal of Acetylcholinesterase Triggers Amyloid‐β Aggregation and Deposition
von: Hou, Li‐Na, et al.
Veröffentlicht: (2013)

Amyloid-β(1–42) Aggregation Initiates Its Cellular Uptake and Cytotoxicity
von: Jin, Sha, et al.
Veröffentlicht: (2016)

Amyloid-β(1–42) Aggregation Initiates Its Cellular Uptake and Cytotoxicity
von: Sha Jin, et al.
Veröffentlicht: (2016)

β‐Amyloid aggregation and heterogeneous nucleation
von: Srivastava, Atul K., et al.
Veröffentlicht: (2019)

β‐Amyloid aggregation and heterogeneous nucleation
von: Atul Srivastava, et al.
Veröffentlicht: (2019)

Aggregation and structure of amyloid β-protein
von: Kenjiro Ono, et al.
Veröffentlicht: (2021)

Inhibition of Amyloid β Protein Aggregation and Neurotoxicity by Rifampicin
von: Takami Tomiyama, et al.
Veröffentlicht: (1996)

Heparin Nanoparticles for β Amyloid Binding and Mitigation of β Amyloid Associated Cytotoxicity
von: Wang, Peng, et al.
Veröffentlicht: (2014)

Angiotensin-converting enzyme 2 is reduced in Alzheimer’s disease in association with increasing amyloid-β and tau pathology
von: Kehoe, Patrick Gavin, et al.
Veröffentlicht: (2016)